바이오칩 시장 보고서(2026년)

Biochips are compact devices containing an assortment of biological substances such as DNA, proteins, or cells, affixed onto a solid surface. They merge biological components with electronic systems for studying and manipulating biological data, finding extensive use in medical diagnostics, genetic sequencing, and other biotechnological domains.

The primary types of biochips include DNA chips (or DNA microarrays), protein chips, lab-on-chip systems, tissue arrays, and cell arrays. DNA chips allow the simultaneous analysis of numerous genes' expressions, leveraging technologies such as microarrays and microfluidics. These biochips find applications in drug discovery, agriculture, genomics, disease diagnostics, proteomics, and are utilized by diverse end users such as biotech firms, pharmaceutical companies, academic institutions, hospitals, and diagnostic centers.

Tariffs are affecting the biochips market by increasing the cost of semiconductor substrates, microfluidic components, biosensor electronics, and assay reagents that rely on global manufacturing and cross-border supply chains, leading to higher production and procurement costs. The impact is more pronounced across dna chips, protein chips, and lab-on-chip platforms manufactured in Asia-Pacific and European hubs where imports of specialty materials and precision components are tariff sensitive. Biotechnology and pharmaceutical companies, academic and research institutes, and hospital diagnostic centers are experiencing extended purchasing cycles and pricing pressures due to tariff-driven cost pass-throughs. However, tariffs are also encouraging localized fabrication, regional component sourcing, and domestic biochip assembly initiatives that may strengthen supply resilience and stimulate long-term innovation investment.

The biochips market research report is one of a series of new reports from The Business Research Company that provides biochips market statistics, including biochips industry global market size, regional shares, competitors with a biochips market share, detailed biochips market segments, market trends and opportunities, and any further data you may need to thrive in the biochips industry. This biochips market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biochips market size has grown rapidly in recent years. It will grow from $14.61 billion in 2025 to $16.97 billion in 2026 at a compound annual growth rate (CAGR) of 16.1%. The growth in the historic period can be attributed to growth in genomics and proteomics research, expansion of pharmaceutical and biotech r&d programs, adoption of dna microarrays in genetic screening, increasing use of biochips in molecular diagnostics, development of microarray and microfluidic-based analytical platforms.

The biochips market size is expected to see rapid growth in the next few years. It will grow to $29.03 billion in 2030 at a compound annual growth rate (CAGR) of 14.4%. The growth in the forecast period can be attributed to rising demand for precision medicine and personalized therapies, growing utilization of lab-on-chip technologies in clinical testing, higher investment in biomarker discovery and translational research, expanding applications of biochips in agriculture and life sciences, increasing commercialization of advanced biochip-based diagnostic tools. Major trends in the forecast period include growing adoption of biochips in genetic sequencing and disease diagnostics, increasing use of protein and cell arrays for advanced biomolecular research, rising demand for lab-on-chip platforms in point-of-care testing, expansion of biochip applications in drug discovery and development, focus on miniaturization and high-throughput biological data analysis.

The biochips market is poised for growth due to the increasing adoption of personalized medicines. Personalized medicine involves tailoring medical treatments based on individual characteristics such as genetics or lifestyle, aiming to optimize effectiveness and minimize adverse effects. This trend is fueled by the potential of personalized medicine to offer more effective treatments, advancements in genomics, the rising complexity of diseases, and regulatory backing. Biochips play a crucial role in personalized medicine by enabling precise and individualized treatment plans based on a person's genetic profile. For instance, in February 2024, the FDA approved 16 novel personalized therapies for rare diseases in 2023, highlighting the momentum in personalized medicine adoption and its impact on the biochips market.

Leading companies in the biochips market are focusing on developing cutting-edge technologies such as organ-on-a-chip platforms to transform drug discovery and development processes. Organ-on-a-chip platforms are sophisticated microfluidic devices designed to mimic the physiological characteristics and functions of human organs on a smaller scale. For example, in April 2024, Boston Micro Fabrication (BMF) launched BMF Biotechnology Inc., specializing in biochips or organ-on-a-chip platforms for cultivating large-scale tissues in vitro. This advancement accelerates drug and cosmetic development by providing a testing and research platform outside the human body.

In June 2023, Randox Laboratories acquired Cellix Limited to bolster its expertise in benchtop flow cytometry, aligning with its commitment to personalized medicine and improved preventive healthcare. This acquisition expands Randox's portfolio and makes flow cytometry technology more accessible to a wider range of researchers and healthcare professionals. Cellix Limited, based in Ireland, specializes in creating biochips for various applications in the life sciences.

Major companies operating in the biochips market are Thermo Fisher Scientific Inc., Roche Diagnostics International Ltd, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan Group Ltd., Cepheid Inc., Randox Laboratories Ltd., Takara Bio Inc., Luminex Corporation, Fluidigm Corporation, Micronit Microtechnologies B.V., Sphere Fluidics Limited, Sengenics, Arrayit Corporation, CustomArray Inc., NanoCellect Biomedical Inc., Dolomite Microfluidics, Biocartis NV

North America was the largest region in the biochips market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biochips market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biochips market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The biochips market consists of sales of lab-on-a-chip (LOC) devices, cellular microarrays, and protein microarrays. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biochips Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses biochips market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biochips ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biochips market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Deoxyribonucleic Acid (DNA) Chips; Protein Chips; Lab-On-Chip; Tissue Arrays; Cell Arrays
• 2) By Technology: Microarrays; Microfluidics
• 3) By Application: Drug Discovery And Development; Agriculture; Genomics; Disease Diagnostics; Proteomics; Other Applications
• 4) By End-User: Biotechnology And Pharmaceutical Companies; Academic And Research Institutes; Hospitals And Diagnostic Centers; Other End-Users
• Subsegments:
• 1) By Deoxyribonucleic Acid (Dna) Chips: Gene Expression Chips; Snp (Single Nucleotide Polymorphism) Chips; Dna Microarrays
• 2) By Protein Chips: Antibody Arrays; Protein Microarrays; Peptide Arrays
• 3) By Lab-On-Chip: Microfluidic Devices; Biosensors
• 4) By Tissue Arrays: Tumor Tissue Arrays; Normal Tissue Arrays
• 5) By Cell Arrays: Cell-Based Biochips; Cell Signaling Arrays
• Companies Mentioned: Thermo Fisher Scientific Inc.; Roche Diagnostics International Ltd; Agilent Technologies Inc.; PerkinElmer Inc.; Illumina Inc.; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Tecan Group Ltd.; Cepheid Inc.; Randox Laboratories Ltd.; Takara Bio Inc.; Luminex Corporation; Fluidigm Corporation; Micronit Microtechnologies B.V.; Sphere Fluidics Limited; Sengenics; Arrayit Corporation; CustomArray Inc.; NanoCellect Biomedical Inc.; Dolomite Microfluidics; Biocartis NV
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Biochips Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Biochips Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Biochips Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Biochips Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Artificial Intelligence & Autonomous Intelligence
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Growing Adoption Of Biochips In Genetic Sequencing And Disease Diagnostics
  • 4.2.2 Increasing Use Of Protein And Cell Arrays For Advanced Biomolecular Research
  • 4.2.3 Rising Demand For Lab-On-Chip Platforms In Point-Of-Care Testing
  • 4.2.4 Expansion Of Biochip Applications In Drug Discovery And Development
  • 4.2.5 Focus On Miniaturization And High-Throughput Biological Data Analysis

5. Biochips Market Analysis Of End Use Industries

• 5.1 Biotechnology And Pharmaceutical Companies
• 5.2 Academic And Research Institutes
• 5.3 Hospitals And Diagnostic Centers
• 5.4 Contract Research Organizations
• 5.5 Public Health And Genomic Research Agencies

6. Biochips Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Biochips Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Biochips PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Biochips Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Biochips Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Biochips Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Biochips Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Biochips Market Segmentation

• 9.1. Global Biochips Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Deoxyribonucleic Acid (DNA) Chips, Protein Chips, Lab-On-Chip, Tissue Arrays, Cell Arrays
• 9.2. Global Biochips Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Microarrays, Microfluidics
• 9.3. Global Biochips Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Drug Discovery And Development, Agriculture, Genomics, Disease Diagnostics, Proteomics, Other Applications
• 9.4. Global Biochips Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Biotechnology And Pharmaceutical Companies, Academic And Research Institutes, Hospitals And Diagnostic Centers, Other End-Users
• 9.5. Global Biochips Market, Sub-Segmentation Of Deoxyribonucleic Acid (DNA) Chips, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Gene Expression Chips, SNP (Single Nucleotide Polymorphism) Chips, DNA Microarrays
• 9.6. Global Biochips Market, Sub-Segmentation Of Protein Chips, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Antibody Arrays, Protein Microarrays, Peptide Arrays
• 9.7. Global Biochips Market, Sub-Segmentation Of Lab-On-Chip, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Microfluidic Devices, Biosensors
• 9.8. Global Biochips Market, Sub-Segmentation Of Tissue Arrays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Tumor Tissue Arrays, Normal Tissue Arrays
• 9.9. Global Biochips Market, Sub-Segmentation Of Cell Arrays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cell-Based Biochips, Cell Signaling Arrays

10. Biochips Market Regional And Country Analysis

• 10.1. Global Biochips Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Biochips Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Biochips Market

• 11.1. Asia-Pacific Biochips Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Biochips Market

• 12.1. China Biochips Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Biochips Market

• 13.1. India Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Biochips Market

• 14.1. Japan Biochips Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Biochips Market

• 15.1. Australia Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Biochips Market

• 16.1. Indonesia Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Biochips Market

• 17.1. South Korea Biochips Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Biochips Market

• 18.1. Taiwan Biochips Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Biochips Market

• 19.1. South East Asia Biochips Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Biochips Market

• 20.1. Western Europe Biochips Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Biochips Market

• 21.1. UK Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Biochips Market

• 22.1. Germany Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Biochips Market

• 23.1. France Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Biochips Market

• 24.1. Italy Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Biochips Market

• 25.1. Spain Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Biochips Market

• 26.1. Eastern Europe Biochips Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Biochips Market

• 27.1. Russia Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Biochips Market

• 28.1. North America Biochips Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Biochips Market

• 29.1. USA Biochips Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Biochips Market

• 30.1. Canada Biochips Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Biochips Market

• 31.1. South America Biochips Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Biochips Market

• 32.1. Brazil Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Biochips Market

• 33.1. Middle East Biochips Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Biochips Market

• 34.1. Africa Biochips Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Biochips Market Regulatory and Investment Landscape

36. Biochips Market Competitive Landscape And Company Profiles

• 36.1. Biochips Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Biochips Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Biochips Market Company Profiles
  • 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Roche Diagnostics International Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Biochips Market Other Major And Innovative Companies

• Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan Group Ltd., Cepheid Inc., Randox Laboratories Ltd., Takara Bio Inc., Luminex Corporation, Fluidigm Corporation, Micronit Microtechnologies B.V., Sphere Fluidics Limited, Sengenics, Arrayit Corporation, CustomArray Inc., NanoCellect Biomedical Inc., Dolomite Microfluidics

38. Global Biochips Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Biochips Market

40. Biochips Market High Potential Countries, Segments and Strategies

• 40.1 Biochips Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Biochips Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Biochips Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer